Vinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo Slider

Cardno ChemRisk Publications

 
Display # 
1 Budinsky, R. A., D. J. Paustenbach, D. Fontaine, B. Landenberger, and T. B. Starr. 2006. Recommended relative potency factors for 2,3,4,7,8 pentachlorodibenzofuran: The impact of different dose metrics. J Toxicol Sci. 91(1):275-85.
2 Cher, D.J., D.C. Deubner, M.A. Kelsh, P.S. Chapman, and R.M. Ray. 2006. Assessment of the Beryllium Lymphocyte Proliferation Test Using Statistical Process Control. Inhal Toxicol. 18(11):901-10.
3 Ferriby, L.L., E.S. Williams, W.J. Luksemburg, D.J. Paustenbach, L.C. Haws, L.S. Birnbaum, and M.A. Harris. 2006. Comparing PCDDs, PCDFs, and dioxin-like PCBs in farm-raised and wild-caught catfish from Southern Mississippi. Organohalogen Compounds. 68:612-15.
4 Ferriby, L.L., E.S. Williams, W.J. Luksemburg, D.J. Paustenbach, L.C. Haws, L.S. Birnbaum, and M.A. Harris. 2006. Comparing polychlorinated biphenyls in farm-raised and wild-caught catfish from Southern Mississippi. Organohalogen Compounds. 68:2527-30.
5 Ferriby, L.L., J.S. Knutsen, M.A. Harris, K.M. Unice, P. Scott, P. Nony, L.C. Haws, and D.J. Paustenbach. 2006. Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001-2002 National Health and Nutrition Examination Survey of the United States population. J Expo Sci Environ Epidemiol. 17:358-371.
6 Haws, L.C., M.J. DeVito, L.S. Birnbaum, N.J. Walker, P.K. Scott, K.M. Unice, M.A. Harris, W.H. Farland, B.L. Finley, and D.F. Staskal. 2006. An alternative method for establishing TEFs for dioxin-like compounds. Part 2. Development of an approach to quantitatively weight the underlying potency data. Organohalogen Compounds. 68:2523-26.
7 Haws, L.C., P.K. Scott, K.M. Unice, M. Gough, M.A. Harris, D.S. Staskal, D.J. Paustenbach, and M. Pavuk. 2006. Are dioxin body burdens surrogates for other risk factors in associations between dioxin diabetes? Organohalogen Compounds. 68:273-276.
8 Haws, L.C., S. Su, M.A. Harris, M.J. DeVito, N. Walker, W. Farland, B.L. Finley, and L. Birnbaum. 2006. Development of a refined database of mammalian relative potency estimates for dioxin-like compounds. Toxicol Sci. 89(1):4-30. http://toxsci.oxfordjournals.org/content/89/1/4.full
9 Jiang, G.C.-T. and M. Aschner. 2006. Neurotoxicity of Depleted Uranium – Reasons for Increased Concern. Biol Trace Elem Res. 110(1):1-18.
10 Kerger, B.D., H.W. Leung, P. Scott, D.J. Paustenbach, L.L. Needham, D.G. Patterson, Jr., P.M. Gerthoux, and P. Mocarelli. 2006. Age- and concentration-dependent elimination of half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso children. Environ Health Perspect. 114(10):1596-602.
11 Leung, H.W., B.D. Kerger, and D.J. Paustenbach. 2006. Elimation half-lives of selected polychlorinated dibenzodioxins and dibenzofurans in breast-fed human infants. J Toxcol Environ Health. 69(6):437-43.
12 Mangold, C., K. Clark, A.K. Madl, and D.J. Paustenbach. 2006. An exposure study of bystanders and workers during the installation and removal of asbestos gaskets and packing. J Occup Environ Hyg. 3(2):87-98.
13 Nguyen, N.P., C. Frank, C.C. Moltz, P. Vos, H.J. Smith, P.D. Nguyen, T. Martinez, H. Lee, L.M. Nguyen, and S. Sallah. 2006. Aspiration rate following nonsurgical therapy for laryngeal cancer. ORL. 69:116-20.
14 Nguyen, N.P., C. Frank, C.C. Moltz, P. Vos, H.J. Smith, P.V. Bhadimipati, U. Karlsson, P.D. Nguyen, A. Alfieri, M.L. Nguyen, C. Lemanski, C. Wayne, S. Rose, and S. Sallah. 2006. Aspiration rate following chemoradiation for head and neck cancer: An underreported occurrence. Radiotherapy Oncol. 80:302-6.
15 Nguyen, N.P., C.C. Moltz, C. Frank, U. Karlsson, H.J. Smith, P. Vos, L.M. Nguyen, S. Rose, S. Dutta, and S. Sallah. 2006. Evolution of chronic dysphagia following treatment for head and neck cancer. Oral Oncol. 42:374-80.
16 Nguyen, N.P., C.C. Moltz, C. Frank, U. Karlsson, P.D. Nguyen, P. Vos, H.J. Smith, S. Dutta, L.M. Nguyen, and S. Sallah. 2006. Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer. Eur J Radiol. 59:453-9.
17 Nguyen, N.P., P. Vos, H.J. Smith, P.D. Nguyen, A. Alfieri, U. Karlsson, S. Dutta, C. Lemanski, L.M. Nguyen, and S. Sallah. 2006. Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol. 28:3-8.
18 Nieuwenhuijsen, M., D.J. Paustenbach and R. Duarte-Davidson. 2006. New developments in exposure assessment: The impact on the practice of health risk assessment and epidemiological studies. Environ Intl. 32:996-1009.
19 Paustenbach, D.J. and D.A. Galbraith. 2006. Biomonitoring and Biomarkers: Exposure assessment will never be the same. Environ Health Perspect. 114(8):1143-9.
20 Paustenbach, D.J. and D.A. Galbraith. 2006. Biomonitoring: Is body burden relevant to public health? Regul Toxicol Pharmacol. 44(3):249-61.
21 Paustenbach, D.J. and S.H. Gaffney. 2006. The role of odor and irritation, as well as risk perception, in the setting of occupational exposure limits. Int Arch Occup Environ Health. 79(4):339-42.
22 Paustenbach, D.J., A.K. Madl, E.P. Donovan, K. Clark, K. Fehling, and T. Lee. 2006. Chrysotile asbestos exposure associated with removal of automobile exhaust systems (ca. 1945-1975) by mechanics: Results of a simulation study. J Expo Sci Environ Epidemiol. 16(2):156-71.
23 Paustenbach, D.J., B.L. Finley, P.J. Sheehan and G.P. Brorby. 2006. Re: Evaluation of the size and type of free particulates collected from unused asbestos-containing brake components as related to potential for respirability. Am J Ind Med. 49:60-1.
24 Paustenbach, D.J., K. Fehling, P. Scott, M. Harris and B.D. Kerger. 2006. Identifying soil cleanup criteria for dioxins in urban residential soils: How have 20 years of research and risk assessment experience affected the analysis? J Toxicol Environ Health. B Crit Rev. 9(2):87-145.
25 Paustenbach, D.J., M.A. Harris, L.L. Ferriby, E.S. Williams, L.C. Haws, K.M. Unice, and P.K. Scott. 2006. Development of PCDD/F TEQ serum reference values for the U.S. population for use in evaluating biomonitoring results. Organohalogen Compounds. 68:480-483.
26 Phelka, A.D., M. Sadoff, B.P. Martin and M.A. Philbert. 2006. BCL-XL Expression Levels Influence Differential Regional Astrocytic Susceptibility to 1,3-Dinitrobenzene. Neurotoxicol. 27(2):192-200.
27 Scott, P.K., L.C. Haws, D.F. Staskal, L.S. Birnbaum, N.J. Walker, M.J. DeVito, M.A. Harris, W.H. Farland, B.L. Finley, and K.M. Unice. 2006. An alternative method for establishing TEFs for dioxin-like compounds. Part 1. Evaluation of decision analysis methods for use in weighting relative potency data. Organohalogen Compounds. 68:2519-2522.
28 Staskal, D.F., J.J. Diliberto, and L.S. Birnbam. 2006. Disposition of BDE 47 in developing mice. Toxicol Sci. 90(2):309-16.
29 Staskal, D.F., J.J. Diliberto, and L.S. Birnbaum. 2006. Impact of repeated exposure on the toxicokinetics of BDE 47 in mice. Toxicol Sci. 89(2):380-5.
30 Staskal, D.F., K.M. Unice, N.J. Walker, M.J. DeVito, L.S. Birnbaum, P.K. Scott, M.A. Harris, W.H. Farland, B.L. Finley, and L.C. Haws. 2006. An alternative method for establishing TEFs for dioxin-like compounds. Part 3. Development of weighted distributions of REPs for PCB 126 and 2,3,4,7,8-PeCDF. Organohalogen Compounds. 68:836-839.
31 Staskal, D.F., L.L. Ferriby, E.S. Williams, W.J. Luksemburg, L.C. Haws, L.S. Birnbaum, D.J. Paustenbach, and M.A. Harris. 2006. Polybrominated diphenyl ethers in southern Mississippi catfish. Organohalogen Compounds. 68:1839-42.
32 Van den Berg, M., L. Birnbaum, M. Denison, M. DeVito, W. Farland, M. Feeley, H. Fiedler, H. Hakansson, A. Hanberg, L.C. Haws, M. Rose, S. Safe, D. Schrenk, C. Tohyama, A. Tritscher, J. Tuomisto, M. Tysklind, N. Walker, and R.E. Peterson. 2006. The 2005 World Health Organization Reevaluation of Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like Compounds. Toxicol Sci. 93(2):223-41.

Search all Publications by author's last name, title or keyword

sidebar_photo_publications